by Scott Larrivee | Oct 1, 2024 | News
Funding supports development and commercialization of broad array of isotopes for medical, commercial and industrial uses VALENCIA, Calif. – Oct. 1, 2024 – Nusano, Inc., a physics company transforming the production of radioisotopes, today announced a Series C...
by Scott Larrivee | Sep 27, 2024 | Blog
September 2024 – Insights Care recently interviewed Nusano CEO Chris Lowe for its “5 Most Trusted Radiopharmaceutical Companies to Watch” edition. Lowe discussed the urgent need for new medical radioisotope supplies, how Nusano will be part of the...
by Scott Larrivee | Sep 27, 2024 | Blog, Utah
Nusano is featured in the 2024 edition of Biosphere magazine entitled “Profiles in Innovation.” Published by BioUtah, the publication highlights advancements occurring throughout Utah’s life sciences industry. In the article, Nusano’s CEO Chris...
by Scott Larrivee | Jul 10, 2024 | News
VALENCIA, Calif. and BOCA RATON, Fla. – July 10, 2024 – Nusano Inc. (Nusano), a physics company transforming the production of medical radioisotopes, and PharmaLogic Holdings Corp. (PharmaLogic), a leading radiopharmaceutical contract development and manufacturing...
by Scott Larrivee | Jun 7, 2024 | News
VALENCIA, Calif. – June 7, 2024 – Nusano, Inc., a physics company transforming the production of medical radioisotopes, today announced industry veteran D. Scott Holbrook as chairman of its board. Holbrook is the co-founder of Invivo Molecular Imaging, and currently...
